TBI treatment 'could be enhanced with diabetes drug'

31 May 2012

Medication already commonly used to thwart the effects of diabetes could also enhance traumatic brain injury (TBI) treatment in the years ahead.

New research commissioned by the United States Air Force has studied the benefits that Exendin-4, an FDA-approved diabetes drug, can have on other health problems.

The study, which was led by professor Chaim Pick, from Tel Aviv University's Sackler Faculty of Medicine, revealed that the medication reduces the damage that animal models are subjected to when suffering TBI.

According to the researchers, the Exendin-4 drug is effective as it can provide enhanced protection to neurons when the body suffers from such disorders as Alzheimer's disease.

Professor Pick commented: "We are moving in the right direction. Now we need to find the right dosage and delivery system, then build a cocktail of drugs that will increase the therapeutic value of this concept."

The research comes soon after a YouGov poll found that 63 per cent of people have expressed concern about dementia and hope to learn more about the serious neurological disorder.

Posted by Jeanette Royston

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...


Diagnostic imaging

© Spire Healthcare Group plc (2016)